Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-084212

President and CEO sold 2,000 shares at $12.00 ($24,000)

From the SEC's structured data for this filing

Trades in this filing

Doshi Dipal · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-07-27 Sale : show line 1 in the form −2,000 $12.00 $24,000 208,710 D
Open-market sales · 2,000 sh · avg $12.00 · $24,000
Loading xslF345X03/tm2222095-2_4seq1.xml…